Castle Creek Biosciences, Inc. Contracts & Agreements
23 Contracts & Agreements
- Business Finance (3 contracts)
- Business Operations (5)
- Human Resources (6)
- Real Estate (3)
- Uncategorized (6)
- Venture Loan and Security Agreement, dated as of February 26, 2020, by and among the Registrant, the Borrowers from time to time party thereto and Horizon Technology Finance... (Filed With SEC on July 16, 2021)
- Castle Creek Biosciences, Inc. Amended and Restated Management Incentive Plan (Filed With SEC on July 16, 2021)
- Form of Option Agreement pursuant to Castle Creek Biosciences, Inc. Amended and Restated Management Incentive Plan (Filed With SEC on July 16, 2021)
- Separation and Release of Claims Agreement, dated May 31, 2021, by and between the Registrant and John Maslowski (Filed With SEC on July 16, 2021)
- Master Consulting Agreement, dated June 24, 2021, by and between the Registrant and John Maslowski (Filed With SEC on July 16, 2021)
- Work Order #1, dated June 24, 2021, incorporated into that certain Master Consulting Agreement, by and between the Registrant and John Maslowski (Filed With SEC on July 16, 2021)
- Work Order #2, dated June 24, 2021, incorporated into that certain Master Consulting Agreement, by and between the Registrant and John Maslowski (Filed With SEC on July 16, 2021)
- Offer Letter, dated September 27, 2016, by and between the Registrant and Gregory Wujek (Filed With SEC on July 16, 2021)
- Offer Letter, dated April 9, 2019, by and between the Registrant and Mary Spellman (Filed With SEC on July 16, 2021)
- Offer Letter, dated February 11, 2021, by and between the Registrant and Matthew Gantz (Filed With SEC on July 16, 2021)
- Lease Agreement, dated as of April 6, 2005, by and between the Registrant (formerly entered into by Isolagen, Inc.) and The Hankin Group (Filed With SEC on July 16, 2021)
- First Amendment to Lease Agreement, dated April 1, 2011, by and between the Registrant (formerly entered into by Fibrocell Science, Inc.) and The Hankin Group (Filed With SEC on July 16, 2021)
- Third Amendment to Lease Agreement, dated May 11, 2021, by and between the Registrant and Hankin Group (Filed With SEC on July 16, 2021)
- Exclusive Channel Collaboration Agreement, dated October 5, 2012, by and between the Registrant (formerly entered into by Fibrocell Science, Inc.) and Intrexon Corporation (now... (Filed With SEC on July 16, 2021)
- First Amendment to Exclusive Channel Collaboration Agreement, dated June 28, 2013, by and between the Registrant (formerly entered into by Fibrocell Science, Inc.) and Intrexon... (Filed With SEC on July 16, 2021)
- Second Amendment to Exclusive Channel Collaboration Agreement, dated January 10, 2014, by and between the Registrant (formerly entered into by Fibrocell Science, Inc.) and... (Filed With SEC on July 16, 2021)
- Letter of Agreement, dated February 19, 2020, by and between the Registrant (formerly entered into by Fibrocell Science, Inc.) and Precigen, Inc (Filed With SEC on July 16, 2021)
- Termination and Modification Agreement, dated March 20, 2020, by and between the Registrant (formerly entered into by Fibrocell Science, Inc.) and Precigen, Inc (Filed With SEC on July 16, 2021)
- Second Amended and Restated Management Services Agreement, dated October 9, 2018, by and between Paragon Biosciences, LLC and Castle Creek Pharmaceuticals, LLC (Filed With SEC on July 16, 2021)
- Right of Use Agreement, dated November 1, 2019, by and between Paragon Biosciences, LLC and Castle Creek Pharmaceuticals, LLC (Filed With SEC on July 16, 2021)
- Letter Agreement, dated June 9, 2021, by and between Paragon Health Capital, LLC and Castle Creek Biosciences, Inc (Filed With SEC on July 16, 2021)
- Amended and Restated Investors Rights Agreement, dated December 9, 2019, by and among the Registrant and the other parties thereto (Filed With SEC on July 16, 2021)
- Convertible Note Purchase Agreement, dated June 28, 2021, by and among the Registrant and the other parties thereto (Filed With SEC on July 16, 2021)
